Relating to Medicaid reimbursement for services provided to certain recipients under a nurse home visiting program.
HB 5152 would require the Texas Health and Human Services Commission to reimburse Medicaid providers for services delivered through a nurse home visiting program to eligible recipients who are pregnant, up to 24 months postpartum, or children age 24 months or younger. The bill defines a qualifying nurse home visiting program as one that provides weekly or monthly nurse-led, home-based pregnancy and postpartum services, offers individualized health and education support, and meets evidence-based standards tied to national or federal Home Visiting Evidence of Effectiveness criteria.
The bill also directs the executive commissioner to set a bundled reimbursement rate covering a broad range of services, including education, screening, counseling, referrals, and support related to maternal health, infant and child development, nutrition, substance use, depression, domestic violence, breastfeeding, preventive care, parenting skills, and access to community resources such as transportation, housing, and public assistance programs. If a recipient loses Medicaid eligibility, the managed care organization must coordinate transfer of the care plan and help ensure continued coverage for the nurse home visiting services. The bill allows telehealth delivery of these services if the commission’s telehealth requirements are met, and it delays implementation of any provision that requires a federal waiver or authorization until that approval is obtained.
HB 5152 would amend Chapter 32 of the Human Resources Code by adding a new Medicaid reimbursement provision for nurse home visiting services. It would expand the scope of reimbursable medical assistance services for pregnant individuals, postpartum recipients, and very young children, and would require HHSC to establish a bundled payment methodology for those services. The bill could also affect managed care coordination, telehealth compliance rules, and the administration of related public assistance referrals, while potentially requiring federal approval before some provisions can take effect.
The available context shows no recorded committee testimony or votes, so there is no direct evidence of support or opposition in the provided materials. Based on the bill’s structure, it appears designed as a maternal and child health access measure, with an emphasis on evidence-based home visiting and continuity of care. The absence of recorded controversy suggests it was at least procedurally noncontroversial at the point it was referred to the House Human Services Committee, though no substantive sentiment can be confirmed from the provided record.
No specific points of contention are documented in the provided committee transcripts or votes. Potential areas that could draw scrutiny, based on the bill text, include the cost of Medicaid reimbursement, the requirement for a bundled rate, the scope of covered services, coordination obligations for managed care organizations when recipients lose eligibility, and whether federal waiver approval would be needed for implementation. However, the record supplied does not identify any legislator, agency, provider, or advocacy group taking a formal position for or against the bill.